Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Hinchliffe

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|December 1, 2020
Natural variants modify Klebsiella pneumoniae carbapenemase (KPC) acyl-enzyme conformational dynamics to extend antibiotic resistanceCatherine L Tooke, Philip Hinchliffe, Robert A Bonomo, et al.
Organic & Biomolecular Chemistry|February 19, 2021
Catalytic mechanism of the colistin resistance protein MCR-1Reynier Suardíaz, Emily Lythell, Philip Hinchliffe, et al.
RSC Medicinal Chemistry|January 22, 2021
Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibitionCatherine L Tooke, Philip Hinchliffe, Alen Krajnc, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Molecular Basis of Class A β-Lactamase Inhibition by RelebactamCatherine L Tooke, Philip Hinchliffe, Pauline A Lang, et al.
Journal of Molecular Biology|April 9, 2019
β-Lactamases and β-Lactamase Inhibitors in the 21st CenturyCatherine L Tooke, Philip Hinchliffe, Eilis C Bragginton, et al.
Journal of the American Chemical Society|March 27, 2023
Tautomer-Specific Deacylation and Ω-Loop Flexibility Explain the Carbapenem-Hydrolyzing Broad-Spectrum Activity of the KPC-2 β-LactamaseCatherine L Tooke, Philip Hinchliffe, Michael Beer, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical IsolatesKarina Calvopiña, Klaus-Daniel Umland, Anna M Rydzik, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Structural and Biochemical Characterization of Rm3, a Subclass B3 Metallo-β-Lactamase Identified from a Functional Metagenomic StudyRamya Salimraj, Lihong Zhang, Philip Hinchliffe, et al.
The Journal of Physical Chemistry. B|September 8, 2025
All Roads Lead to Carbinolamine: QM/MM Study of Enzymatic C-N Bond Cleavage in Anaerobic Glycyl Radical Enzyme Choline Trimethylamine-Lyase (CutC)Marko Hanzevacki, J Jasmin Güven, Philip Hinchliffe, et al.
Scientific Reports|September 22, 2019
Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product CharacterisationChristopher T Lohans, Emily I Freeman, Emma van Groesen, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|December 1, 2020
Natural variants modify Klebsiella pneumoniae carbapenemase (KPC) acyl-enzyme conformational dynamics to extend antibiotic resistanceCatherine L Tooke, Philip Hinchliffe, Robert A Bonomo, et al.
Organic & Biomolecular Chemistry|February 19, 2021
Catalytic mechanism of the colistin resistance protein MCR-1Reynier Suardíaz, Emily Lythell, Philip Hinchliffe, et al.
RSC Medicinal Chemistry|January 22, 2021
Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibitionCatherine L Tooke, Philip Hinchliffe, Alen Krajnc, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Molecular Basis of Class A β-Lactamase Inhibition by RelebactamCatherine L Tooke, Philip Hinchliffe, Pauline A Lang, et al.
Journal of Molecular Biology|April 9, 2019
β-Lactamases and β-Lactamase Inhibitors in the 21st CenturyCatherine L Tooke, Philip Hinchliffe, Eilis C Bragginton, et al.
Journal of the American Chemical Society|March 27, 2023
Tautomer-Specific Deacylation and Ω-Loop Flexibility Explain the Carbapenem-Hydrolyzing Broad-Spectrum Activity of the KPC-2 β-LactamaseCatherine L Tooke, Philip Hinchliffe, Michael Beer, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical IsolatesKarina Calvopiña, Klaus-Daniel Umland, Anna M Rydzik, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Structural and Biochemical Characterization of Rm3, a Subclass B3 Metallo-β-Lactamase Identified from a Functional Metagenomic StudyRamya Salimraj, Lihong Zhang, Philip Hinchliffe, et al.
The Journal of Physical Chemistry. B|September 8, 2025
All Roads Lead to Carbinolamine: QM/MM Study of Enzymatic C-N Bond Cleavage in Anaerobic Glycyl Radical Enzyme Choline Trimethylamine-Lyase (CutC)Marko Hanzevacki, J Jasmin Güven, Philip Hinchliffe, et al.
Scientific Reports|September 22, 2019
Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product CharacterisationChristopher T Lohans, Emily I Freeman, Emma van Groesen, et al.
Pageof 6